LymphedemaV1, Pmc, Corpus, bibRecord, 003868

Lymphedema Following Treatment for Breast Cancer: A New Approach to an Old Problem

Identifieur interne : 003868 ( Pmc/Corpus ); précédent : 003867; suivant : 003869

Lymphedema Following Treatment for Breast Cancer: A New Approach to an Old Problem

Auteurs : Jean O Oole ; Lauren Jammallo ; Melissa Skolny ; Cynthia Miller ; Krista Elliott ; Michelle Specht ; Alphonse G. Taghian

Source :

Critical reviews in oncology/hematology [ 1040-8428 ] ; 2013.

RBID : PMC:3784614

Abstract

Lymphedema following treatment for breast cancer can be an irreversible condition with a profound negative impact on quality of life. The lack of consensus regarding standard definitions of clinically significant lymphedema and optimal methods of measurement and quantification are unresolved problems. Inconsistencies persist regarding the appropriate timing of intervention and what forms of treatment should be the standard of care. There are reports that early detection and intervention can prevent progression, however the Level 1 evidence to support this hypothesis has yet to be generated. To assess these controversies, we propose the implementation of a screening program to detect early lymphedema in conjunction with a randomized, prospective trial designed to generate Level 1 evidence regarding the efficacy of early intervention and appropriate treatment strategies. Collaboration among institutions that manage breast cancer patients is essential to establish a standardized approach to lymphedema and to establish guidelines for best practice.

Url:

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3784614

DOI: 10.1016/j.critrevonc.2013.05.001
PubMed: 23777977
PubMed Central: 3784614

Links to Exploration step

PMC:3784614

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Lymphedema Following Treatment for Breast Cancer: A New Approach to an Old Problem</title>
<author><name sortKey="O Oole, Jean" sort="O Oole, Jean" uniqKey="O Oole J" first="Jean" last="O Oole">Jean O Oole</name>
<affiliation><nlm:aff id="A1">Department of Physical Therapy, Massachusetts General Hospital. Harvard Medical School, Boston, MA, 02114</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Jammallo, Lauren" sort="Jammallo, Lauren" uniqKey="Jammallo L" first="Lauren" last="Jammallo">Lauren Jammallo</name>
<affiliation><nlm:aff id="A2">Department of Radiation Oncology, Massachusetts General Hospital. Harvard Medical School, Boston, MA, 02114</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Skolny, Melissa" sort="Skolny, Melissa" uniqKey="Skolny M" first="Melissa" last="Skolny">Melissa Skolny</name>
<affiliation><nlm:aff id="A2">Department of Radiation Oncology, Massachusetts General Hospital. Harvard Medical School, Boston, MA, 02114</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Miller, Cynthia" sort="Miller, Cynthia" uniqKey="Miller C" first="Cynthia" last="Miller">Cynthia Miller</name>
<affiliation><nlm:aff id="A2">Department of Radiation Oncology, Massachusetts General Hospital. Harvard Medical School, Boston, MA, 02114</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Elliott, Krista" sort="Elliott, Krista" uniqKey="Elliott K" first="Krista" last="Elliott">Krista Elliott</name>
<affiliation><nlm:aff id="A3">Department of Surgical Oncology, Massachusetts General Hospital. Harvard Medical School, Boston, MA, 02114</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Specht, Michelle" sort="Specht, Michelle" uniqKey="Specht M" first="Michelle" last="Specht">Michelle Specht</name>
<affiliation><nlm:aff id="A3">Department of Surgical Oncology, Massachusetts General Hospital. Harvard Medical School, Boston, MA, 02114</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Taghian, Alphonse G" sort="Taghian, Alphonse G" uniqKey="Taghian A" first="Alphonse G." last="Taghian">Alphonse G. Taghian</name>
<affiliation><nlm:aff id="A2">Department of Radiation Oncology, Massachusetts General Hospital. Harvard Medical School, Boston, MA, 02114</nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">23777977</idno>
<idno type="pmc">3784614</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3784614</idno>
<idno type="RBID">PMC:3784614</idno>
<idno type="doi">10.1016/j.critrevonc.2013.05.001</idno>
<date when="2013">2013</date>
<idno type="wicri:Area/Pmc/Corpus">003868</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">003868</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Lymphedema Following Treatment for Breast Cancer: A New Approach to an Old Problem</title>
<author><name sortKey="O Oole, Jean" sort="O Oole, Jean" uniqKey="O Oole J" first="Jean" last="O Oole">Jean O Oole</name>
<affiliation><nlm:aff id="A1">Department of Physical Therapy, Massachusetts General Hospital. Harvard Medical School, Boston, MA, 02114</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Jammallo, Lauren" sort="Jammallo, Lauren" uniqKey="Jammallo L" first="Lauren" last="Jammallo">Lauren Jammallo</name>
<affiliation><nlm:aff id="A2">Department of Radiation Oncology, Massachusetts General Hospital. Harvard Medical School, Boston, MA, 02114</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Skolny, Melissa" sort="Skolny, Melissa" uniqKey="Skolny M" first="Melissa" last="Skolny">Melissa Skolny</name>
<affiliation><nlm:aff id="A2">Department of Radiation Oncology, Massachusetts General Hospital. Harvard Medical School, Boston, MA, 02114</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Miller, Cynthia" sort="Miller, Cynthia" uniqKey="Miller C" first="Cynthia" last="Miller">Cynthia Miller</name>
<affiliation><nlm:aff id="A2">Department of Radiation Oncology, Massachusetts General Hospital. Harvard Medical School, Boston, MA, 02114</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Elliott, Krista" sort="Elliott, Krista" uniqKey="Elliott K" first="Krista" last="Elliott">Krista Elliott</name>
<affiliation><nlm:aff id="A3">Department of Surgical Oncology, Massachusetts General Hospital. Harvard Medical School, Boston, MA, 02114</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Specht, Michelle" sort="Specht, Michelle" uniqKey="Specht M" first="Michelle" last="Specht">Michelle Specht</name>
<affiliation><nlm:aff id="A3">Department of Surgical Oncology, Massachusetts General Hospital. Harvard Medical School, Boston, MA, 02114</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Taghian, Alphonse G" sort="Taghian, Alphonse G" uniqKey="Taghian A" first="Alphonse G." last="Taghian">Alphonse G. Taghian</name>
<affiliation><nlm:aff id="A2">Department of Radiation Oncology, Massachusetts General Hospital. Harvard Medical School, Boston, MA, 02114</nlm:aff>
</affiliation>
</author>
</analytic>
<series><title level="j">Critical reviews in oncology/hematology</title>
<idno type="ISSN">1040-8428</idno>
<idno type="eISSN">1879-0461</idno>
<imprint><date when="2013">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p id="P2">Lymphedema following treatment for breast cancer can be an irreversible condition with a profound negative impact on quality of life. The lack of consensus regarding standard definitions of clinically significant lymphedema and optimal methods of measurement and quantification are unresolved problems. Inconsistencies persist regarding the appropriate timing of intervention and what forms of treatment should be the standard of care. There are reports that early detection and intervention can prevent progression, however the Level 1 evidence to support this hypothesis has yet to be generated. To assess these controversies, we propose the implementation of a screening program to detect early lymphedema in conjunction with a randomized, prospective trial designed to generate Level 1 evidence regarding the efficacy of early intervention and appropriate treatment strategies. Collaboration among institutions that manage breast cancer patients is essential to establish a standardized approach to lymphedema and to establish guidelines for best practice.</p>
</div>
</front>
</TEI>
<pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
  <pmc-dir>properties manuscript</pmc-dir>
  <front><journal-meta><journal-id journal-id-type="nlm-journal-id">8916049</journal-id>
<journal-id journal-id-type="pubmed-jr-id">1454</journal-id>
<journal-id journal-id-type="nlm-ta">Crit Rev Oncol Hematol</journal-id>
<journal-id journal-id-type="iso-abbrev">Crit. Rev. Oncol. Hematol.</journal-id>
<journal-title-group><journal-title>Critical reviews in oncology/hematology</journal-title>
</journal-title-group>
<issn pub-type="ppub">1040-8428</issn>
<issn pub-type="epub">1879-0461</issn>
</journal-meta>
<article-meta><article-id pub-id-type="pmid">23777977</article-id>
<article-id pub-id-type="pmc">3784614</article-id>
<article-id pub-id-type="doi">10.1016/j.critrevonc.2013.05.001</article-id>
<article-id pub-id-type="manuscript">NIHMS482435</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Article</subject>
</subj-group>
</article-categories>
<title-group><article-title>Lymphedema Following Treatment for Breast Cancer: A New Approach to an Old Problem</article-title>
</title-group>
<contrib-group><contrib contrib-type="author"><name><surname>O’Toole</surname>
<given-names>Jean</given-names>
</name>
<degrees>PT, MPH, CLT-LANA</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref rid="FN2" ref-type="author-notes">*</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Jammallo</surname>
<given-names>Lauren</given-names>
</name>
<degrees>BS</degrees>
<xref ref-type="aff" rid="A2">2</xref>
<xref rid="FN2" ref-type="author-notes">*</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Skolny</surname>
<given-names>Melissa</given-names>
</name>
<degrees>MSHA</degrees>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Miller</surname>
<given-names>Cynthia</given-names>
</name>
<degrees>BS</degrees>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Elliott</surname>
<given-names>Krista</given-names>
</name>
<degrees>NP</degrees>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Specht</surname>
<given-names>Michelle</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Taghian</surname>
<given-names>Alphonse G.</given-names>
</name>
<degrees>MD, PhD.</degrees>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>
Department of Physical Therapy, Massachusetts General Hospital. Harvard Medical School, Boston, MA, 02114</aff>
<aff id="A2"><label>2</label>
Department of Radiation Oncology, Massachusetts General Hospital. Harvard Medical School, Boston, MA, 02114</aff>
<aff id="A3"><label>3</label>
Department of Surgical Oncology, Massachusetts General Hospital. Harvard Medical School, Boston, MA, 02114</aff>
<author-notes><corresp id="FN1">CORRESPONDING AUTHOR: Alphonse G. Taghian, MD, PhD, Professor of Radiation Oncology, Harvard Medical School, Department of Radiation Oncology, Cox 3 Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, <email>ataghian@partners.org</email>
; Tel: 617-726-7559; Fax: 617-726-3603</corresp>
<fn id="FN2" fn-type="equal"><label>*</label>
<p>First and second authors contributed equally to the manuscript</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted"><day>7</day>
<month>6</month>
<year>2013</year>
</pub-date>
<pub-date pub-type="epub"><day>16</day>
<month>6</month>
<year>2013</year>
</pub-date>
<pub-date pub-type="ppub"><month>11</month>
<year>2013</year>
</pub-date>
<pub-date pub-type="pmc-release"><day>01</day>
<month>11</month>
<year>2014</year>
</pub-date>
<volume>88</volume>
<issue>2</issue>
<fpage>437</fpage>
<lpage>446</lpage>
<permissions><copyright-statement>© 2013 Elsevier Ireland Ltd. All rights reserved.</copyright-statement>
<copyright-year>2013</copyright-year>
</permissions>
<abstract><p id="P2">Lymphedema following treatment for breast cancer can be an irreversible condition with a profound negative impact on quality of life. The lack of consensus regarding standard definitions of clinically significant lymphedema and optimal methods of measurement and quantification are unresolved problems. Inconsistencies persist regarding the appropriate timing of intervention and what forms of treatment should be the standard of care. There are reports that early detection and intervention can prevent progression, however the Level 1 evidence to support this hypothesis has yet to be generated. To assess these controversies, we propose the implementation of a screening program to detect early lymphedema in conjunction with a randomized, prospective trial designed to generate Level 1 evidence regarding the efficacy of early intervention and appropriate treatment strategies. Collaboration among institutions that manage breast cancer patients is essential to establish a standardized approach to lymphedema and to establish guidelines for best practice.</p>
</abstract>
<kwd-group><kwd>lymphedema</kwd>
<kwd>screening</kwd>
<kwd>perometer</kwd>
<kwd>breast cancer</kwd>
</kwd-group>
<funding-group><award-group><funding-source country="United States">National Cancer Institute : NCI</funding-source>
<award-id>R01 CA139118 || CA</award-id>
</award-group>
</funding-group>
</article-meta>
</front>
</pmc>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Pmc/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003868 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 003868 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Pmc
   |étape=   Corpus
   |type=    RBID
   |clé=     PMC:3784614
   |texte=   Lymphedema Following Treatment for Breast Cancer: A New Approach to an Old Problem
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i   -Sk "pubmed:23777977" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le lymphœdème

Lymphedema Following Treatment for Breast Cancer: A New Approach to an Old Problem

Lymphedema Following Treatment for Breast Cancer: A New Approach to an Old Problem

Source :

Abstract

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki